Unipharm, Inc.
Unipharm, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded medications. Unipharm's core offerings include a diverse range of pharmaceutical products, with a focus on injectables, oral solids, and topical formulations. What sets Unipharm apart is its commitment to innovation and quality, ensuring that all products meet stringent regulatory standards. With a strong market position, Unipharm has achieved significant milestones, including numerous FDA approvals and partnerships that enhance its product portfolio. The company continues to strive for excellence, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Unipharm, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Unipharm, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Unipharm, Inc.'s reported carbon emissions
Unipharm, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Unipharm's climate commitments and strategies remain unclear, and there is no inherited emissions data from a parent or related organisation. The absence of reported emissions and reduction initiatives highlights a potential area for development in their sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Unipharm, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
